Terns Pharmaceuticals, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Terns Pharmaceuticals, Inc.
CIK #0001831363
EDGAR Form CIK 2011 - 2025
10-K [0001831363]
10-Q [0001831363]
3 [0001831363]
4 [0001831363]
8-K [0001831363]
D [0001831363]
SC 13D [0001831363]
SC 13G [0001831363]
Form 13D/13G Filer Form 13D/13G Subject Filed
Morgan Stanley Terns Pharmaceuticals Inc [2025-05-07]
BlackRock Inc Terns Pharmaceuticals Inc [2024-11-08]
BlackRock Inc Terns Pharmaceuticals Inc [2024-10-24]
Citadel Advisors LLC Terns Pharmaceuticals Inc [2024-07-22]
Soleus Capital Master Fund LP Terns Pharmaceuticals Inc [2024-06-07]
Point72 Asset Management LP Terns Pharmaceuticals Inc [2024-03-07]
BlackRock Inc Terns Pharmaceuticals Inc [2024-01-31]
Integrated Core Strategies US LLC Terns Pharmaceuticals Inc [2024-01-25]
Deep Track Capital LP Terns Pharmaceuticals Inc [2023-07-28]
Millennium Management LLC Terns Pharmaceuticals Inc [2023-06-27]
View All
Form 3/4/5 Subject 2011 - 2025
Kuriakose Emil
Terns Pharmaceuticals, Inc.
Gengos Andrew
Burroughs Amy L.
Turner Heather D
Tripuraneni Radhika
Lu Hongbo
Fellows David A
Quigley Jill M.
Kindler Jeffrey B
View All
Terms | Privacy | Guide
tony@aum13f.com